FEBS LettersMicrobiologyPeer-reviewed journal article
Fluorescence-based CRISPR interference system for controlled genetic repression and live single-cell imaging in mycobacteria
Janïs Laudouze, Vanessa Point, Wafaa Achache, Céline CrausteiD, Stéphane CanaaniD, Pierre SantucciiD
Abstract
Mycobacterial genetics has played a pivotal role over the last 35 years in our understanding of mycobacterial physiology, pathogenesis and antibiotic resistance. Numerous approaches are now available worldwide to dissect the contribution of genes of interest in biological processes. However, many of these approaches can be fastidious, difficult to perform and time-consuming, especially when working with slow-growing mycobacteria or in bio-safety level two/three settings. The recent development of CRISPRi-mediated targeted gene repression has revolutionized the way research groups can perform genetics in mycobacteria, providing a fast, robust and efficient alternative to study the function of specific genes including essential genes. In this research letter, we report the development and validation of a new subset of fluorescence-based CRISPRi tools for our scientific community. The pJL series is directly derived from the original integrative pIRL2 and pIRL117 CRISPRi vectors and conserved all the elements required to perform inducible targeted gene repression. In addition, these vectors carry two distinct fluorescent markers for which the expression is driven by the strong and constitutive promotor psmyc to simplify the selection of recombinant clones. We demonstrate the functionality of these vectors by targeting the expression of the non-essential glycopeptidolipid translocase mmpL4b and the essential genes rpoB and mmpL3. Finally, we describe an efficient single-step procedure to co-transform mycobacterial species with this integrative genetic tool alongside replicative vectors. Such tools and approaches should be useful to foster discovery in mycobacterial research. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=104 SRC="FIGDIR/small/616838v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@212460org.highwire.dtl.DTLVardef@1db5529org.highwire.dtl.DTLVardef@b426e2org.highwire.dtl.DTLVardef@164f628_HPS_FORMAT_FIGEXP M_FIG C_FIG Development and validation of a new subset of E. coli-Mycobacteria shuttle vectors that enable simultaneous CRISPRI-mediated gene silencing and fluorescence based single-cell imaging.
- assay: fluorescence / live-cell microscopy
- research focus: genome assembly
- research focus: gene regulatory network inference
- research focus: clustering
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 3
- FWCI
- 0.39
- Field percentile
- top 46%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mycobacterial cell division arrest and smooth-to-rough envelope transition using CRISPRi-mediated genetic repression systems
Vanessa Point, Wafaa Achache, … Pierre Santucci·FEBS Open BioPeer-reviewed·Nov 30, 2025
- An Alternative, Cas12a-based CRISPR Interference System for Mycobacteria
Neil D. Fleck, Christoph Grundner·Journal of Biological ChemistryPeer-reviewed·Jul 21, 2021
- CRISPRi-Seq for the Identification and Characterisation of Essential Mycobacterial Genes and Transcriptional Units
Timothy J. de Wet, Irene Gobe, … Digby F. Warner·bioRxiv·Jun 29, 2018
- CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis
Matthew B. McNeil, Laura M. Keighley, … Gregory Murray Cook·Molecular MicrobiologyPeer-reviewed·Aug 4, 2021
- CRISPRi-mediated validation of candidate Myocobacterium abscessus drug targets during host infection
Rashmi Gupta, Breven S. Simcox, Kyle H. Rohde·bioRxiv·Dec 17, 2025
- A CRISPR interference platform for selective downregulation of gene expression in Borrelia burgdorferi
C. N. Takacs, M. Scott, … C. Jacobs-Wagner·bioRxiv·Oct 12, 2020